elective caesarean section
ProcedureProcedure performed at 38 weeks and 3 days of gestation (+/- 2 days)
Other names: Elective surgery, Planned caesarean section
NCT Number: NCT00835003
The caesarean section rate is rising globally. About 10% of the newborns are submitted to a neonatal department after planned caesarean section, primarily with respiratory disorders. More children are submitted if caesarean is performed earlier in pregnancy.
Study hypothesis: More newborns are admitted after planned caesarean at 38 weeks and 3 days of gestation than after 39 weeks and 3 days of gestation.
Aim of study: To compare elective caesarean section performed at 38 weeks and 3 days of gestation with 39 weeks and 3 days of gestation. According to this timing to determine the proportion of newborns admitted within 48 hours after birth.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
University Hospital of Odense, Odense, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Procedure performed at 38 weeks and 3 days of gestation (+/- 2 days)
Other names: Elective surgery, Planned caesarean section
Time frame: 48 hours
Time frame: 30 days
Time frame: 30 days
Time frame: 30 days
Time frame: 30 days
Time frame: 2 months
Time frame: 2 months
Time frame: 2 months post partum
Time frame: From birth until 2 years of age
Aarhus University Hospital
Other
Timing of Elective Caesarean Section and Neonatal Morbidity - a Randomised Multicentre Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03894969
Chronic Disease, DNA Virus Infections
Tallinn, Estonia
View Trial DetailsNCT03443427
Respiration Disorders, Respiratory Disorders
Truro, Nova Scotia, Canada
View Trial DetailsNCT03151395
Chronic Disease, Disease Attributes
Kowloon, Hong Kong
View Trial DetailsNCT03201211
Respiration Disorders, Respiratory Disorders
Ghent, Belgium
View Trial Details